# Nanobiotix S.A.: Form 20-F/A for the period ended Dec 31, 2020

- Company: [Nanobiotix S.A.](/companies/nbtx.md) (CIK 1760854)
- Form: 20-F/A
- Filed: 2021-04-08
- Accepted by EDGAR: Apr 7, 2021, 18:03 ET
- Period: 2020-12-31
- Accession: 0001628280-21-006685
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1760854/000162828021006685/nbx-20201231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1760854/000162828021006685/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2020-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2020-01-01 to 2020-12-31 | EUR 2.5m | ifrs-full:Revenue |
| Operating income | 12 months, 2020-01-01 to 2020-12-31 | −EUR 36.4m | ifrs-full:ProfitLossFromOperatingActivities |
| Income tax | 12 months, 2020-01-01 to 2020-12-31 | EUR 9.0k | ifrs-full:IncomeTaxExpenseContinuingOperations |
| Net income | 12 months, 2020-01-01 to 2020-12-31 | −EUR 33.6m | ifrs-full:ProfitLossAttributableToOwnersOfParent |
| Diluted EPS | 12 months, 2020-01-01 to 2020-12-31 | −EUR 1.38 | ifrs-full:DilutedEarningsLossPerShare |
| Basic EPS | 12 months, 2020-01-01 to 2020-12-31 | −EUR 1.38 | ifrs-full:BasicEarningsLossPerShare |
| Operating cash flow | 12 months, 2020-01-01 to 2020-12-31 | −EUR 27.5m | ifrs-full:CashFlowsFromUsedInOperatingActivities |
| Capital expenditure | 12 months, 2020-01-01 to 2020-12-31 | EUR 96.0k | ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
| Cash and equivalents | at 2020-12-31 | EUR 119.2m | ifrs-full:CashAndCashEquivalents |
| Current assets | at 2020-12-31 | EUR 125.2m | ifrs-full:CurrentAssets |
| Total assets | at 2020-12-31 | EUR 134.0m | ifrs-full:Assets |
| Current liabilities | at 2020-12-31 | EUR 19.0m | ifrs-full:CurrentLiabilities |
| Shareholders' equity | at 2020-12-31 | EUR 70.5m | ifrs-full:Equity |
| Shares outstanding | at 2020-12-31 | 34,432,122 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1760854/000162828021006685/nbx-20201231.htm

Filed Apr 8, 2021.
Source: SEC EDGAR, the filing index for accession 0001628280-21-006685. Last ingested by Listed: Oct 26, 2026, 06:02 ET. No prices; not investment advice.